Bai J, Yang G, Yu Q, Chi Q, Zeng X, Qi W
Front Oncol. 2025; 15:1535929.
PMID: 40071088
PMC: 11893431.
DOI: 10.3389/fonc.2025.1535929.
Tao S, Ji Y, Li R, Xiao Y, Wu H, Ye R
ACS Omega. 2025; 10(6):5886-5899.
PMID: 39989842
PMC: 11840594.
DOI: 10.1021/acsomega.4c09755.
Li S, Zhang L, Zhang W, Chen H, Hong M, Xia J
Chin Med. 2025; 20(1):23.
PMID: 39953557
PMC: 11829537.
DOI: 10.1186/s13020-025-01074-5.
Sun L, Zuo C, Ma B, Liu X, Guo Y, Wang X
Chin Herb Med. 2025; 17(1):156-165.
PMID: 39949814
PMC: 11814247.
DOI: 10.1016/j.chmed.2024.06.001.
Liu X, Zhang G, Zhao L
Cytojournal. 2025; 21:65.
PMID: 39917003
PMC: 11801651.
DOI: 10.25259/Cytojournal_107_2024.
Clinical utility of quantitative ultrasonography parameters combined with serum cancer antigen 15‑3, human epidermal growth factor receptor 2 and soluble E‑cadherin in diagnosing mass‑type breast cancer.
Hu K, Wang Y, Ma Y, Xiu C
Oncol Lett. 2025; 29(3):133.
PMID: 39822943
PMC: 11737295.
DOI: 10.3892/ol.2025.14879.
Integrated immune-related gene signature predicts clinical outcome for patients with Luminal B breast cancer.
Xie Z, Cai D, Ye R, Shan Z, Lin Y, Gao F
Gland Surg. 2025; 13(12):2253-2263.
PMID: 39822362
PMC: 11733651.
DOI: 10.21037/gs-24-377.
MRPL24 drives breast cancer metastasis and stemness by targeting c-MYC, BRD4, and STAT3.
Khan A, Khan I, Man S, Liu S, Ailun G, Abbas M
3 Biotech. 2025; 15(2):37.
PMID: 39802327
PMC: 11718041.
DOI: 10.1007/s13205-024-04196-z.
Intra-tumoral sphingobacterium multivorum promotes triple-negative breast cancer progression by suppressing tumor immunosurveillance.
Mai Z, Fu L, Su J, To K, Yang C, Xia C
Mol Cancer. 2025; 24(1):6.
PMID: 39780177
PMC: 11708301.
DOI: 10.1186/s12943-024-02202-9.
The protective role of baicalin regulation of autophagy in cancers.
Zhang Q, Guo S, Ge H, Wang H
Cytotechnology. 2025; 77(1):33.
PMID: 39760060
PMC: 11699138.
DOI: 10.1007/s10616-024-00689-0.
Factors Affecting Non-sentinel Lymph Node Metastasis in Early-Stage Breast Cancer.
Demircioglu Z, Demircioglu M, Tanik C, Yetkin S
Cureus. 2024; 16(11):e74199.
PMID: 39712801
PMC: 11663538.
DOI: 10.7759/cureus.74199.
DYRK2 controls GSTPI expression through ubiquitination and degradation of Twist1 to reduce chemotherapy resistance caused by EMT in breast cancer.
Xu G, Zhou M, Li Q, Li Y, Zhang C, Yang Z
J Mol Histol. 2024; 56(1):35.
PMID: 39641870
DOI: 10.1007/s10735-024-10300-7.
First-line endocrine therapy combined with CDK 4/6 inhibitor in disseminated carcinomatosis of bone marrow (DCBM) luminal breast cancer: a case report.
Pangarsa E, Astuti P, Rizky D, Tandarto K, Setiawan B, Winarno A
J Med Case Rep. 2024; 18(1):591.
PMID: 39633462
PMC: 11619148.
DOI: 10.1186/s13256-024-04922-4.
Investigating tumor immunogenicity in breast cancer: deciphering the tumor immune response to enhance therapeutic approaches.
Naji O, Ghouzlani A, Rafii S, Sadiqi R, Kone A, Harmak Z
Front Immunol. 2024; 15:1399754.
PMID: 39507526
PMC: 11538072.
DOI: 10.3389/fimmu.2024.1399754.
Mangiferin: An effective agent against human malignancies.
Irshad N, Naeem H, Shahbaz M, Imran M, Mujtaba A, Hussain M
Food Sci Nutr. 2024; 12(10):7137-7157.
PMID: 39479608
PMC: 11521646.
DOI: 10.1002/fsn3.4434.
Machine learning-guided synthesis of nanomaterials for breast cancer therapy.
Zhou K, Tian B, Lu J, Dong B, Xu H
Sci Rep. 2024; 14(1):25795.
PMID: 39468211
PMC: 11519650.
DOI: 10.1038/s41598-024-76924-7.
Can we skip invasive biopsy of sentinel lymph nodes? A preliminary investigation to predict sentinel lymph node status using PET/CT-based radiomics.
Yang L, Ding H, Gao X, Xu Y, Xu S, Wang K
BMC Cancer. 2024; 24(1):1316.
PMID: 39455907
PMC: 11515836.
DOI: 10.1186/s12885-024-13031-w.
Psychological Distress Among Women With Breast Cancer in Saudi Arabia: A Phenomenological Study.
Alghamdi Y, Alsharqi O, Ismail A
Cureus. 2024; 16(9):e69701.
PMID: 39429287
PMC: 11489889.
DOI: 10.7759/cureus.69701.
Tumor-intrinsic role of ICAM-1 in driving metastatic progression of triple-negative breast cancer through direct interaction with EGFR.
Kang J, Uddin N, Kim S, Zhao Y, Yoo K, Kim M
Mol Cancer. 2024; 23(1):230.
PMID: 39415210
PMC: 11481280.
DOI: 10.1186/s12943-024-02150-4.
LncRNA XIST/miR-455-3p/HOXC4 axis promotes breast cancer development by activating TGF-β/SMAD signaling pathway.
Zhao S, Song C, Chen F, Li M
Funct Integr Genomics. 2024; 24(5):159.
PMID: 39261346
DOI: 10.1007/s10142-024-01442-8.